Clinical Research Directory
Browse clinical research sites, groups, and studies.
SCRIPT: Sickle Cell Risk in Pregnancy Tool
Sponsor: Mount Sinai Hospital, Canada
Summary
Sickle Cell Disease (SCD), common in persons of Black ancestry, affects the shape of hemoglobin, the oxygen-carrying part of red blood cells (RBC). It is characterized by many complications, the most dreaded of which are related to pregnancy - affecting both the mother and unborn child. Compared to those without SCD, people with SCD have more adverse pregnancy outcomes (APO): 6x maternal mortality, 2x preeclampsia \& preterm birth, 4x risk of having a baby not growing well in the womb \& stillbirth. There is also greater need for access to care (7x higher hospitalization often multiple times lasting days to months). Yet up to 30% of SCD pregnancies are uncomplicated. Treatments in pregnancy are limited and carry risks. A method to distinguish pregnancies at high-risk of APO that may benefit from these potentially risky treatments, from those likely to be uncomplicated, is urgently needed. To meet this need, the investigators developed a calculator to estimate pregnancy complication risk, using single-centre data. Its accuracy and precision will now be evaluated with international information from several centers by testing the calculator, and adjusting it as needed, using already available pregnancy-data from study centres in several countries. Those age \>16 years, who have a confirmed SCD genotype, pregnancy with one baby, and pregnancy care and birth at a participating study centre will be included. Pregnancy care for the participants will be up to their doctors, with no changes based on the study. SCRIPT - the new tool - will guide future care by predicting who may benefit from specific treatments, reducing harm to low-risk individuals \& will allow selection of high-risk patients for a future trials to determine whether currently available and novel treatments in well-selected patients can improve APO sufficiently to balance treatment-related harms.
Official title: Prediction of Adverse Outcomes in Pregnancies of Individuals With Sickle Cell Disease - SCRIPT: Sickle Cell Risk in Pregnancy Tool
Key Details
Gender
FEMALE
Age Range
16 Years - 60 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2024-09-01
Completion Date
2026-12
Last Updated
2024-11-27
Healthy Volunteers
No
Interventions
Non-Interventional
Non-Interventional
Locations (3)
Johns Hopkins University
Baltimore, Maryland, United States
Providence Health Care
Vancouver, British Columbia, Canada
Centre hospitalier de l'Université de Montréal
Montreal, Quebec, Canada